Aethlon Medical(AEMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AEMD Aethlon Medical

Market Closed 06-28 16:00:00 EDT

0.4987

-0.0799

-13.81%

盘后0.4800

-0.0187-3.75%

19:59 EDT

High0.5497	Low0.4825	Vol1.71M
Open0.5281	D1 Closing0.5786	Amplitude11.61%
Mkt Cap6.93M	Tradable Cap6.83M	Total Shares13.90M
T/O877.37K	T/O Rate12.47%	Tradable Shares13.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"AEMD","market":"US","secType":"STK","nameCN":"Aethlon Medical","latestPrice":0.4987,"timestamp":1719604800000,"preClose":0.5786,"halted":0,"volume":1707769,"hourTrading":{"tag":"盘后","latestPrice":0.48,"preClose":0.4987,"latestTime":"19:59 EDT","volume":50319,"amount":24575.1159,"timestamp":1719619186419},"delay":0,"floatShares":13694000,"shares":13899725,"eps":-5.038754,"marketStatus":"Market Closed","change":-0.0799,"latestTime":"06-28 16:00:00 EDT","open":0.5281,"high":0.5497,"low":0.4825,"amount":877372.04477615,"amplitude":0.116142,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5.038754,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1719820800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.5786,"preHourTrading":{"tag":"盘前","latestPrice":0.5207,"preClose":0.5786,"latestTime":"09:29 EDT","volume":141078,"amount":73594.28392259999,"timestamp":1719581370586},"postHourTrading":{"tag":"盘后","latestPrice":0.48,"preClose":0.4987,"latestTime":"19:59 EDT","volume":50319,"amount":24575.1159,"timestamp":1719619186419},"volumeRatio":0.8944530439008944,"impliedVol":3.8125,"impliedVolPercentile":0.9577},"requestUrl":"/m/hq/s/AEMD/tweets","defaultTab":"tweets","newsList":[{"id":"2446595212","title":"Aethlon Medical Inc reports results for the quarter ended in March - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2446595212","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446595212?lang=en_us&edition=fundamental","pubTime":"2024-06-28 05:36","pubTimestamp":1719524163,"startTime":"0","endTime":"0","summary":"* Aethlon Medical Inc    reported a quarterly adjusted loss of 91 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $-1.00.  The ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD"],"gpt_icon":0},{"id":"2446988925","title":"BRIEF-Aethlon Medical Announces Financial Results For The Fiscal Year Ended March 31, 2024 And Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2446988925","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446988925?lang=en_us&edition=fundamental","pubTime":"2024-06-28 04:30","pubTimestamp":1719520224,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc   :   * AETHLON MEDICAL ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL YEAR ENDED MARCH 31, 2024 AND PROVIDES CORPORATE UPDATESource text for Eikon:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD"],"gpt_icon":0},{"id":"2446560015","title":"BRIEF-Aethlon Medical- Co Received Multiple Inquiries Regarding Current, Multi-State Outbreak Of H5n1 Avian Influenza (H5n1 Hpai) Virus In Dairy Cattle","url":"https://stock-news.laohu8.com/highlight/detail?id=2446560015","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446560015?lang=en_us&edition=fundamental","pubTime":"2024-06-28 04:29","pubTimestamp":1719520173,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc   :   * AETHLON MEDICAL- CO RECEIVED MULTIPLE INQUIRIES REGARDING CURRENT, MULTI-STATE OUTBREAK OF H5N1 AVIAN INFLUENZA  VIRUS IN DAIRY CATTLE   * AETHLON MEDICAL INC -CO HAS NOT TESTED ITS HEMOPURIFIER AGAINST CURRENT STRAIN NOR HAVE THERE BEEN MANY CASES OF  CURRENT STRAIN INFECTING HUMANSSource text for Eikon:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU0061475181.USD","IE0034235188.USD","AEMD","BK4135","BK4082","BK4568","STT","BK4583"],"gpt_icon":0},{"id":"2446599579","title":"Aethlon Medical GAAP EPS of -$4.86 beats by $0.33","url":"https://stock-news.laohu8.com/highlight/detail?id=2446599579","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446599579?lang=en_us&edition=fundamental","pubTime":"2024-06-28 04:18","pubTimestamp":1719519515,"startTime":"0","endTime":"0","summary":"Aethlon Medical press release  (NASDAQ:AEMD): FY  GAAP EPS of -$4.86  beats by $0.33.\nAs of March 31, 2024, Aethlon Medical had a cash balance of approximately $5.4 million and as of June 25, 2024, had a cash balance of approximately $9.1 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4120347-aethlon-medical-gaap-eps-of-4_86-beats-0_33","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["AEMD"],"gpt_icon":0},{"id":"2446656046","title":"Aethlon Medical FY 2024 GAAP EPS $(4.86) Beats $(5.22) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2446656046","media":"Benzinga","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446656046?lang=en_us&edition=fundamental","pubTime":"2024-06-28 04:17","pubTimestamp":1719519465,"startTime":"0","endTime":"0","summary":"Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.86) per share which beat the analyst consensus estimate of $(5.22) by 6.9 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/06/39536293/aethlon-medical-fy-2024-gaap-eps-4-86-beats-5-22-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD"],"gpt_icon":0},{"id":"2446560906","title":"Press Release: Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2446560906","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446560906?lang=en_us&edition=fundamental","pubTime":"2024-06-28 04:15","pubTimestamp":1719519300,"startTime":"0","endTime":"0","summary":"Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update. SAN DIEGO, June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal year ended March 31, 2024 and provided an update on recent developments.\"During the fourth quarter and subsequent period, we have continued to make significant progress advancing towards our planned, safety, feasibility and dose finding oncology trials in Australia and India, punctuated by the recent approval from the Human Research Ethics Committee at Central Adelaide Local Health Network,\" stated James Frakes, Interim Chief Executive Officer and Chief Financial Officer of Aethlon Medical. \"Upon submission to the Therapeutic Goods Administration, the national health regulatory","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD"],"gpt_icon":0},{"id":"2446458117","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2446458117","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446458117?lang=en_us&edition=fundamental","pubTime":"2024-06-27 18:00","pubTimestamp":1719482400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Acuity Brands Inc.                               3Q      4.08   6:00 AM. ·Apogee Enterp Inc.                              1Q      1.04   6:30 AM. ·McCormick & Company Incorporated                 2Q       .59   6:30 AM. ·NIKE Inc. Class B                                4Q       .84   4:15 PM. ·Simply Good Foods Co                            3Q       .48   7:00 AM. ·Walgreens Boots Alliance Inc.                    3Q       .68   7:00 AM. ·MSC Indus Direct Co. Inc. Class A                3Q      1.34   6:30 AM. ·Constellation Brands Inc. Class A                1Q      3.46   7:30 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYI","NKE","BK4128","PNST","STZ","MSM","MKC","MKC.V","LU2552382215.SGD","BK4585","LU2404859741.USD","BK4086","BK4581","AEMD","SMPL","BK4566","BK4142","LNN","LU0321505439.SGD","LU0786609619.USD","BK4096","BK4167","LU2552382058.USD","LU0321505868.SGD","BK4196","BK4568","LU0690374615.EUR","LU1303367103.USD","GB00B4LPDJ14.GBP","LU2098885051.SGD","BK4152","BK4104","BK4533","LU2404859667.USD","GB00B4QBRK32.GBP","BK4561","WBA","APOG","BK4588","LU0823411888.USD","BK4082","BK4146","ACCD","BK4169","BK4212","SLP","LU2552382132.HKD","BK4534","BK4558","LU0690374961.EUR"],"gpt_icon":0},{"id":"2446344644","title":"Aethlon Medical FY 2024 Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2446344644","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446344644?lang=en_us&edition=fundamental","pubTime":"2024-06-27 05:35","pubTimestamp":1719437700,"startTime":"0","endTime":"0","summary":"Aethlon Medical  is scheduled to announce FY earnings results on Thursday, June 27th, after market close. The consensus EPS Estimate is -$5.19. Over the last 2 years, AEMD has beaten EPS estimates 50% of the time and has beaten revenue estimates 13% of the time.  Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4119545-aethlon-medical-fy-2024-earnings-preview","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["AEMD"],"gpt_icon":0},{"id":"2446884954","title":"Aethlon Medical Inc    expected to post a loss of $1.23 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2446884954","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446884954?lang=en_us&edition=fundamental","pubTime":"2024-06-25 05:02","pubTimestamp":1719262939,"startTime":"0","endTime":"0","summary":"* Aethlon Medical Inc     is expected to show a fall in quarterly revenue when it reports  results on June 27 for the period ending March 31 2024   *    * LSEG's mean analyst estimate for Aethlon Medi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD"],"gpt_icon":1},{"id":"2445072660","title":"HC Wainwright Adjusts Aethlon Medical Price Target to $7 From $10, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2445072660","media":"MT Newswires Live","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445072660?lang=en_us&edition=fundamental","pubTime":"2024-06-24 21:47","pubTimestamp":1719236863,"startTime":"0","endTime":"0","summary":"Price: 0.59, Change: -0.01, Percent Change: -1.72","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AEMD"],"gpt_icon":0},{"id":"2445071487","title":"Aethlon Medical Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2445071487","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445071487?lang=en_us&edition=fundamental","pubTime":"2024-06-24 21:15","pubTimestamp":1719234900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AEMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 24, 2024 09:15 ET (13:15 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD"],"gpt_icon":0},{"id":"2446077420","title":"AEMD: Ethics Committee Approval for Safety, Feasibility, Dose-Finding Trial Important Step in Advancing the Hemopurifier","url":"https://stock-news.laohu8.com/highlight/detail?id=2446077420","media":"Zacks Small Cap Research","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2446077420?lang=en_us&edition=fundamental","pubTime":"2024-06-24 20:58","pubTimestamp":1719233880,"startTime":"0","endTime":"0","summary":"CALHN has granted full ethics approval for Hemopurifier safety, feasibility & dose-finding clinical trial. Study will assess the Hemopurifier in cancer patients receiving anti-PD-1 monotherapy treatment. Unfortunately, only ~ 30% of patients receiving anti-PD-1 monotherapy treatment have lasting responses. Combined Hemopurifier / immunotherapy treatment might improve outcomes for a higher percent of patients. Separately, AEMD plans to release FY 2024 results on June 27, 2024. That means that the majority of patients do not respond to checkpoint inhibitors. Aethlon’s hypothesis is that using the Hemopurifier in conjunction with treatment of checkpoint inhibitors can increase the percent of patients who can benefit from combined treatment.AEMD hypothesis is that combined Hemopurifier / Immunotherapy treatment can improve outcomes for a higher percent of patients. The company expects the Hemopurifier, in conjunction with an inhibitor, can help","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hjNLDFoh2th_hJcxDR6Fzg--~B/aD04MjQ7dz0xNTY0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/17e3f4f8a82d97c155913a28a95646a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hjNLDFoh2th_hJcxDR6Fzg--~B/aD04MjQ7dz0xNTY0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/17e3f4f8a82d97c155913a28a95646a2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aemd-ethics-committee-approval-safety-125800095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BSNM7G36.USD","LU0122379950.USD","IE00BLSP4452.SGD","LU1974910355.USD","LU1057294990.SGD","MRK","SG9999014542.SGD","LU2023250843.SGD","BK4588","SG9999001440.SGD","IE00B1BXHZ80.USD","SG9999001176.USD","AEMD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0965509283.SGD","IE00BBT3K403.USD","SG9999013999.USD","LU1989771016.USD","BK4534","IE00BLSP4239.USD","LU0266013472.USD","LU0070302665.USD","BK4082","LU1023059063.AUD","LU2361044949.HKD","LU0208291251.USD","LU1093756168.USD","LU1093756325.SGD","LU1989772923.USD","LU0965509101.SGD","LU0234572021.USD","LU0211331839.USD","LU2361045086.USD","LU1066051498.USD","LU1291159041.SGD","LU2106854487.HKD","IE0002141913.USD","LU2361044865.SGD","BK4533","BK4007","SG9999001176.SGD","LU0289739699.SGD","LU1430594728.SGD","LU1989772840.SGD","LU0965509010.AUD","IE00BJT1NW94.SGD","LU1585245621.USD","LU0238689110.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2445026418","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2445026418","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445026418?lang=en_us&edition=fundamental","pubTime":"2024-06-24 18:00","pubTimestamp":1719223200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Carnival plc Sp ADR                              2Q      (.01)  9:15 AM. NIKE Inc. Class B                                4Q       .84   4:15 PM. (Companies tentatively scheduled to report quarterly earnings during the next five trading days. At least three brokerage analysts must be forecasting an EPS for the company t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","SMPL","WOR","FC","SNX","CUK","CNXC","APOG","GIS","AMC","MKC.V","NKE","CDMO","FDX","PAYX","JEF","UNF","BK4106","IE0002270589.USD","BK4082","LU0661504455.SGD","LU2286300806.USD","BK4547","LU0082616367.USD","LEVI","BK4187","LU1585245621.USD","LNN","LVO","PRGS","BK4532","GBX","PNST","AYI","FUL","IE00B7SZLL34.SGD","LU0251142724.SGD","LU0823411888.USD","WBA","MLKN","BK4109","MU","BK4226","MKC","AEMD","ACCD","AVAV","XAIR","LU0792757196.USD"],"gpt_icon":0},{"id":"2445754591","title":"Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2445754591","media":"PR Newswire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445754591?lang=en_us&edition=fundamental","pubTime":"2024-06-21 20:01","pubTimestamp":1718971260,"startTime":"0","endTime":"0","summary":"SAN DIEGO, June 21, 2024 /PRNewswire/ --Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal year ended March 31, 2024, at 4:15 p.m. ET on Thursday, June 27, 2024.Interested parties without internet access or unable to pre-register may dial in by calling:. PARTICIPANT DIAL IN : 1-844-836-8741PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5442. All callers should ask for the Aethlon Medical, Inc. conference call.A replay of the call will be available approximately one hour after the end of the call through July 27, 2024. The replay can be accessed via Aethlon Medical's website or by dialing 1-877-344-7529  or 1-412-317-0088  or Canada toll free at 1-855-669-9658. The replay conference ID number is 6876352.Company Contact:Jim FrakesInterim Chief Executive Officer and Chief Financial OfficerAethlon Medical, Inc. Jfrakes@aethlonmedical.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/zfOjqiAZgW9N3e3xTlAHuQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/b14cd9a6b167a6a2e15f523d003ebf22","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/zfOjqiAZgW9N3e3xTlAHuQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/b14cd9a6b167a6a2e15f523d003ebf22"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aethlon-medical-release-fiscal-end-120100863.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aethlon-medical-release-fiscal-end-120100863.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4181","AEMD","BK4583","IDE","BK4568","BK4218","BK4588","HST","BK4585"],"gpt_icon":0},{"id":"2444296816","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2444296816","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2444296816?lang=en_us&edition=fundamental","pubTime":"2024-06-20 18:00","pubTimestamp":1718877600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Accenture Plc Class A                            3Q      3.16   6:44 AM. ·Commercial Metals Company                        3Q      1.02   6:45 AM. ·Darden Restaurants Inc.                          4Q      2.61   7:00 AM. ·FactSet Research Syss Inc.                       3Q      3.91   7:00 AM. ·Beyond Air Inc.                                 4Q      (.47)  4:05 PM. ·Progress Software Corp.                         2Q       .95   4:15 PM. ·TD SYNNEX Corp.                                  2Q      2.82   8:05 AM. ·Worthington Enterp Inc.                          4Q       .88   4:30 PM. ·Franklin Covey Co.                                3Q       .39   4:05 PM. ·Levi Strauss & Co. Class A                      2Q       .11       AMC","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FUL","PAYX","KR","BK4557","WOR","LU1989763690.USD","BK4099","WGO","GMS","BK4097","FDS","SG9999014914.USD","SNX","JBL","LU0323240290.USD","FC","DRI","LU1169590202.USD","BK4007","KMX","BK4112","MLKN","LEVI","ACB","BK4567","JEF","BK4559","LU0511384066.AUD","GIS","ACN","LU1989763427.SGD","MU","IE00B19Z3B42.SGD","AEMD","SVCO","LVO","XAIR","CMC","MEI","SG9999017495.SGD","CNXC","PRGS","UNF","CUK","CDMO","FDX","AVAV","BK4566","BK4123"],"gpt_icon":0},{"id":"2444484669","title":"BRIEF-Aethlon Medical Receives Ethics Committee Approval For Hemopurifier® Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2444484669","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2444484669?lang=en_us&edition=fundamental","pubTime":"2024-06-18 20:23","pubTimestamp":1718713420,"startTime":"0","endTime":"0","summary":"June 18  - Aethlon Medical Inc   :   * AETHLON MEDICAL RECEIVES ETHICS COMMITTEE APPROVAL FOR HEMOPURIFIER CANCER TRIAL   * AETHLON MEDICAL INC:  ON JUNE 13, HREC OF CENTRAL ADELAIDE LOCAL HEALTH NETWORK GRANTED FULL ETHICS APPROVAL FOR CO'S CLINICAL TRIAL OF HEMOPURIFIERSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AEMD","BK4568","BK4583"],"gpt_icon":0},{"id":"2444484477","title":"Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2444484477","media":"PR Newswire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2444484477?lang=en_us&edition=fundamental","pubTime":"2024-06-18 20:01","pubTimestamp":1718712060,"startTime":"0","endTime":"0","summary":"Aethlon Medical Granted Full Ethics Approval From the Human Research Ethics Committee at Central Adelaide Local Health Network for a Safety, Feasibility, and Dose Finding Study of its Hemopurifier in Cancer Patients with Solid Tumors Not Responding to Anti-PD-1 Antibodies. The primary endpoint of the approximate 18-patient, safety, feasibility and dose-finding trial is safety. The trial will monitor any adverse events and clinically significant changes in lab tests of Hemopurifier treated patients with solid tumors with stable or progressive disease at different treatment intervals, after a two-month run in period of PD-1 antibody, K","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MQjUh39OeOtH.Pg60RHqJg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/937fc2f1f03434a86b8466133bb282aa","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MQjUh39OeOtH.Pg60RHqJg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/937fc2f1f03434a86b8466133bb282aa"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/aethlon-medical-receives-ethics-committee-120100142.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aethlon-medical-receives-ethics-committee-120100142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","AEMD","BK4568","IDE","BK4082"],"gpt_icon":0},{"id":"2441305712","title":"The Hunt for Virus Treatments Continues Post Covid-19","url":"https://stock-news.laohu8.com/highlight/detail?id=2441305712","media":"Newsfile","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2441305712?lang=en_us&edition=fundamental","pubTime":"2024-06-07 20:00","pubTimestamp":1717761600,"startTime":"0","endTime":"0","summary":"Vancouver, Kelowna, and Delta, British Columbia-- - Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of viruses, featuring Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases.The threat of viruses is back in the news with multiple news sources, including the Guardian reporting, \"The World Health Organization  has said a man's death in Mexico was caused by a strain of bird flu called H5N2 that has never before been found in a human.\". Aethlon Medical, Inc.  just recently announced an update on its technology for cancer treatment on its planned phase 1 safety, feasibility and dose-finding clinical trials of its Hemopurifier in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda or Opdivo.According to their SEC filing, \"We also believe the He","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8x6Qvr5H_8T0p399V4oQag--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/fe7d7b75eab2189cd4b74881ce32cbc4","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8x6Qvr5H_8T0p399V4oQag--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/fe7d7b75eab2189cd4b74881ce32cbc4"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/hunt-virus-treatments-continues-post-120000282.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hunt-virus-treatments-continues-post-120000282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BNTX","BK4212","BK4548","BK4082","BK4535","POST","BK4551","BK4583","AEMD","BK4588","BK4585","BK4568"],"gpt_icon":0},{"id":"2440989864","title":"Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID","url":"https://stock-news.laohu8.com/highlight/detail?id=2440989864","media":"Newsfile","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2440989864?lang=en_us&edition=fundamental","pubTime":"2024-06-03 21:05","pubTimestamp":1717419900,"startTime":"0","endTime":"0","summary":"Vancouver, Kelowna, and Delta, British Columbia-- - Investorideas.com, a go-to investing platform, releases the first of a two-part series looking at medical device advancements for blood purification, featuring Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases.Aethlon Medical, Inc. , with a long history of development for its patented Hemopurifier blood purification device, just released an update on its planned phase 1 safety, feasibility and dose-finding clinical trials of its Hemopurifier in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda or Opdivo.The Aethlon Hemopurifier is a first-in-class technology designed for the rapid depletion of cancer-promoting exosomes and circulating viruses. The United States Food and Drug Administration  has designated the Hemopurifier as a \"Breakthrough Device\" for the treatment of ind","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NyAcxrKI3s6RsOe6pfCYBA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/c951f74d1964c09a22d7f775a3a0016d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NyAcxrKI3s6RsOe6pfCYBA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/c951f74d1964c09a22d7f775a3a0016d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/blood-purification-medical-devices-revolutionizing-130500219.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/blood-purification-medical-devices-revolutionizing-130500219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","ICU","AEMD","BK4583","IDE","BK4568"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aethlonmedical.com","stockEarnings":[{"period":"1week","weight":-0.1676},{"period":"1month","weight":0.1874},{"period":"3month","weight":-0.7032},{"period":"6month","weight":-0.7723},{"period":"1year","weight":-0.875},{"period":"ytd","weight":-0.7723}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0344},{"period":"3month","weight":0.0404},{"period":"6month","weight":0.145},{"period":"1year","weight":0.2422},{"period":"ytd","weight":0.145}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.471639},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.149923},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.101527},{"month":4,"riseRate":0.111111,"avgChangeRate":-0.123823},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.137562},{"month":6,"riseRate":0.888889,"avgChangeRate":0.28379},{"month":7,"riseRate":0.25,"avgChangeRate":-0.065909},{"month":8,"riseRate":0.111111,"avgChangeRate":-0.155963},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.061405},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.08424},{"month":11,"riseRate":0.444444,"avgChangeRate":0.008655},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.057891}],"exchange":"NASDAQ","name":"Aethlon Medical","nameEN":"Aethlon Medical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aethlon Medical(AEMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aethlon Medical(AEMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aethlon Medical,AEMD,Aethlon Medical股票,Aethlon Medical股票老虎,Aethlon Medical股票老虎国际,Aethlon Medical行情,Aethlon Medical股票行情,Aethlon Medical股价,Aethlon Medical股市,Aethlon Medical股票价格,Aethlon Medical股票交易,Aethlon Medical股票购买,Aethlon Medical股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aethlon Medical(AEMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aethlon Medical(AEMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction